Sabine Kuratli is now in charge of manufacturing at DiNAMIQS

DINMIQS is welcoming Sabine Kuratli. Sabine joined at the beginning of this month as our new Head of Manufacturing & MSAT.

With more than 20 years of experience in biopharmaceutical development, GMP manufacturing and Manufacturing Science & Technology (MSAT), Sabine brings extensive expertise in developing and executing CMC strategies, process development, technology transfer, scale-up, process validation and lifecycle management.

Throughout her career, she has held leadership and CMC roles across global pharmaceutical companies, innovative biotech organizations and global health initiatives, including Johnson & Johnson, Crucell and CEPI. Her experience leading international manufacturing networks and building strong CDMO partnerships will be invaluable as we continue to advance innovative cell and gene therapy manufacturing.

“I’m excited to join DINAMIQS at such an exciting stage of its journey. The combination of scientific excellence, manufacturing expertise and a shared commitment to transforming genetic medicine into success stories makes this a truly inspiring team. I look forward to working alongside my colleagues and partners to help accelerate the development and manufacture of next-generation cell and gene therapies.” — Dr. Sabine Kuratli